Powered by
-NICE says patients accessing more cancer drugs following price drops

Patients will have routine access to more cancer drugs as companies have dropped their prices as part of the reformed Cancer Drugs Fund (CDF) process.

NICE is now halfway through the drugs it is considering from the CDF and so far all have been recommended for routine NHS use. Companies have provided discounts and in some cases additional evidence meaning the drugs can be considered cost effective for routine NHS use.

pills drugs capsules

The CDF was established by the Governme

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox
Related News Feeds

Mentioned Entities

See how you can reach these people and organizations